Emergent Biosolutions reported $1.27B in Current Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Chimerix CMRX:US 62.55M 33.25M
Immunogen IMGN:US $ 456.72M 22.03M
IONIS PHARMACEUT IONS:US $ 2345M 189.26M
Ironwood Pharmaceuticals IRWD:US $ 710.1M 35.12M
Lonza Group LONN:SW 5.96B 925M
Myriad Genetics MYGN:US $ 484.8M 14.1M
Nektar Therapeutics NKTR:US $ 795.58M 190.55M
Xoma XOMA:US $ 89.61M 7.36M